Completed

AVPEDSurgical Complications in Children Post-Bladder Augmentation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from past medical records and data - Retrospective
Who is being recruted

Congenital Abnormalities+13

+ Urogenital Diseases

+ Urinary Bladder Diseases

Until 17 Years
+2 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: November 2020
See protocol details

Summary

Principal SponsorUniversity Hospital, Clermont-Ferrand
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 1, 2020

Actual date on which the first participant was enrolled.

From 1982 to 2020, all patients who had an enterocystoplasty in childhood were collected. Complications were numbered depending on the type of enterocystoplasty and the investigators tried to find which risk factors exist.

Official TitleSurgical Complications After Bladder Augmentation in Children: a Retrospective Study About 87 Patients
NCT06733194
Principal SponsorUniversity Hospital, Clermont-Ferrand
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

87 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Until 17 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Congenital AbnormalitiesUrogenital DiseasesUrinary Bladder DiseasesUrinary Bladder, NeurogenicFemale Urogenital Diseases and Pregnancy ComplicationsCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System MalformationsNervous System DiseasesNeural Tube DefectsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrologic DiseasesSpinal DysraphismFemale Urogenital DiseasesMale Urogenital Diseases

Criteria

1 inclusion criteria required to participate
Patients who underwent a enterocystoplasty before 18 years old
1 exclusion criteria prevent from participating
Patients who underwent a enterocystoplasty after 18 years old

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Clermont-Ferrand University Hospital

Clermont-Ferrand, FranceOpen Clermont-Ferrand University Hospital in Google Maps
CompletedOne Study Center